leisure time -WSS

leisure time

author：Wikipedia 2025-09-29 14:15:44 - browse：73

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Supreme Court mifepristone arguments center on docs' right to sue

WSS

Eliminate the waiting period for sterilization covered by Medicaid

FDA rejects Alnylam's heart disease treatment over insufficient data

Merck drug for rare lung condition set for approval in U.S.

There's no autism epidemic. It's an autism diagnosis epidemic

A virus, fished out of a lake, may have saved a man’s life

Food as medicine: Medically tailored meals may get standardized

Wikipedia

leisure time

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Patient advocates debate FDA's accelerated approval process

Medicare proposal to cover medical devices draws a mixed reaction

Readout LOUD podcast: mifepristone case, GLP

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Novavax promises a turnaround & Lilly roils the obesity market

Vertex Pharmaceuticals may move headquarters in Boston

The cancer drug shortage isn’t new — and neither are the solutions

Covid vaccine financial winners and losers, from Pfizer to Novavax

focus

Histogen: Failed biotech offers rare public look inside

Patient advocates debate FDA's accelerated approval process

FDA's naming rule on biosimilars has undermined competition

Scientists boost immune system in aging mice by making it youthful

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Scientists boost immune system in aging mice by making it youthful

explore

explore

explore

hotspot